Wednesday, 8 April 2026
  
Login

Australia's most trusted
source of pharma news

Wednesday, 08 April 2026
News

SOS distress call for PBS listing

Posted 8 April 2026 AM

With three months remaining until the PBAC considers Sanofi’s revised proposal for Dupixent in younger children, Eczema Support Australia has issued an SOS distress call on behalf of families of Australian children with severe eczema.

The SOS for Kids with Eczema campaign aims to end a long-standing injustice that forces children to wait until their twelfth birthday before receiving effective treatment.

To see the whole article, please login

Popular

After 1192 days, is funding in sight?
And again... MA fills media role
Who's on a major hiring spree?
Trump tariffs unleash hidden chaos
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (14)

Clinical & Medical, R&D (6)

Regulatory, Pharmacovigilance & QA (4)

Other (8)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home